# Liminatus Pharma, Inc.: Form DEF 14A, filed Jul 13, 2026

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: DEF 14A
- Filed: 2026-07-13
- Accepted by EDGAR: Jul 13, 2026, 08:43 ET
- Period: 2026-08-03
- Accession: 0001104659-26-082905
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926082905/tm264954-2_def14.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465926082905/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465926082905/tm264954-2_def14.htm

Filed Jul 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-082905. Last ingested by Listed: Nov 3, 2026, 19:32 ET. No prices; not investment advice.